Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
10/2003
10/08/2003CN1123355C Medicine for treating pyelonephritis
10/08/2003CN1123354C Medicine for treating pulmonary heart diseases
10/08/2003CN1123353C Chinese patent medicine for treating nenoxenia
10/08/2003CN1123352C Cold eliminating pills
10/08/2003CN1123349C Powder for increasing spermic and helping conception
10/08/2003CN1123348C Capsule for treating rheumatic and rheumatoid arthritis and its preparing process
10/08/2003CN1123347C Chinese medicine for decreasing fat and losing weight and prepn. method thereof
10/08/2003CN1123346C Animal cartilage health-care capsule for inhibiting tumour growth, eliminating free radical and anti peroxidation of lipid and prepn. method thereof
10/08/2003CN1123293C Moisture bacteriocin disinfectant wipes and methods of using same
10/08/2003CA2424683A1 Hla matching donor-originating activated lymphocytes to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases, treatment method achieved by using the lymphocytes, formula having the lymphocytes as a main constituent thereof, method for manufacturing the formula and preparation kit to be used to prepare the formula
10/07/2003US6630574 Compositions and methods for the therapy and diagnosis of lung cancer
10/07/2003US6630480 Methods of treating leukemia
10/07/2003US6630349 Trophoblast cell preparations
10/07/2003US6630326 Cancer diagnosis and therapy based on mutations in TGF-β receptors
10/07/2003US6630305 Compositions and methods for the therapy and diagnosis of prostate cancer
10/07/2003US6630179 Oxihumic acid and its use in the treatment of various conditions
10/07/2003US6630178 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
10/07/2003CA2237807C Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
10/07/2003CA2207286C Localized delivery of factors enhancing survival of transplanted cells
10/02/2003WO2003080823A2 Bacteriophages useful for therapy and prophylaxis of bacterial infections
10/02/2003WO2003080822A1 Placenta-origin mesenchymal cells and medicinal use thereof
10/02/2003WO2003080817A1 Process for producing cytotoxic lymphocyte
10/02/2003WO2003080813A2 Lactobacillus strains
10/02/2003WO2003080801A2 Adipose stromal stem cells for tissue and vascular modification
10/02/2003WO2003080798A2 Muscle cells and their use in cardiac repair
10/02/2003WO2003080649A2 Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors
10/02/2003WO2003080640A1 Lymphatic and blood endothelial cell genes
10/02/2003WO2003080122A1 Method and agent for producing therapeutically active blood compositions
10/02/2003WO2003080116A1 Modulating angiogenesis
10/02/2003WO2003080094A1 Product for regression of tumors occuring in the human body
10/02/2003WO2003080093A1 A process for the preparation of a new medicinal combination for regression of intracranial tumors and other tumors occurring in the human body
10/02/2003WO2003080083A1 Use of adenoviruses mutated in the va genes for cancer treatment
10/02/2003WO2003080082A1 Compositions containing labile bioactive materials and mammalian colostrum, methods of preparation and treatment
10/02/2003WO2003079967A2 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
10/02/2003WO2003079818A1 Alertness bar
10/02/2003WO2003079757A2 Hiv therapeutic
10/02/2003WO2003062414A3 Methods of obtaining isoform specific expression in mammalian cells
10/02/2003WO2003057862A3 Transdifferentiation of pancreatic acinar cells
10/02/2003WO2003043669A8 Composition and method for treatment of wounds
10/02/2003WO2003006950A3 Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
10/02/2003WO2003004655A3 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences
10/02/2003WO2002036748A3 Methods for depleting and isolating alloreactive and antigen-reactive t cells from hematopoietic donor cells
10/02/2003WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
10/02/2003WO2002002623A3 Compositions and methods for the therapy and diagnosis of lung cancer
10/02/2003WO2001086307A3 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
10/02/2003US20030187515 Dry decellularized amniotic membrane capable of being stored at room temperature and subsequent to rehydration can be used for a variety of medical and/or research purposes
10/02/2003US20030186936 Gene therapy; lyases; hyaluronidase; anticancer agents (retinoblastomas); kits
10/02/2003US20030186908 Microorganisms transformed with Ig-Like polypeptide and uses thereof
10/02/2003US20030186907 Endometrial function
10/02/2003US20030186902 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner
10/02/2003US20030186852 Compositions and methods for controlling plant pests
10/02/2003US20030186841 Ligand activated transcriptional regulator proteins
10/02/2003US20030186440 Preparing cellular adjuvant for treatment of neoplastic and infectious diseases; immunotherapy; antitumor agents
10/02/2003US20030186439 Cloned totipotent hepatic cells for treating diseases of the digestive system; tissue engineering
10/02/2003US20030186434 Method of forming vertebrate pancreas in vitro
10/02/2003US20030186419 Masp-3, a complement-fixing enzyme, and uses for it
10/02/2003US20030186406 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
10/02/2003US20030186392 Biopolymer thickener
10/02/2003US20030186391 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purpose
10/02/2003US20030186271 Pharmaceutical compositions in particulate form
10/02/2003US20030186269 Ssa-56 kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
10/02/2003US20030186264 Comprises enzymatic polypeptide for diagnosis and treatment of genetic disorders; drug screening; immunoassay; high throughput assay
10/02/2003US20030186232 Human and non-human primate homologues of Nkd protein, nucleic acid sequences encoding, and uses thereof
10/02/2003US20030186213 Storage solution containing photosensitizer for inactivation of biological contaminants
10/02/2003US20030185905 Plant extracts for the treatment of increased bone resorption
10/02/2003US20030185853 Produced by inoculating koji mold on a pulse crop to effect koji preparation and adding water to hydrolyze proteins and/ or saccharides contained in said product
10/02/2003US20030185852 Parasitic protozoan isolate
10/02/2003US20030185830 Compositions and methods for the therapy and diagnosis of prostate cancer
10/02/2003US20030185823 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient.
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003US20030185811 Herbal extract and preparation thereof
10/02/2003US20030185809 First population of mammalian cells transfected or transduced with a gene that is sought to be expressed, and a second population of mammalian cells that have not been transfected or transduced with the gene
10/02/2003US20030185807 Administering a cell that expresses at least one factor of the T-box family, such as brachyury.
10/02/2003US20030185806 Intact cells that express major histocompatibility antigens with a number of common allotypes from a given mammalian species.
10/02/2003US20030185805 Use of stem cells derived from dermal skin
10/02/2003US20030185802 DNA construct operably encoding a vascular endothelial growth factor receptor protein.
10/02/2003US20030185794 Such as a pleiotrophin or midkine molecule in a pharmaceutically acceptable carrier.
10/02/2003US20030185702 Methods for sterilizing tissue
10/02/2003CA2480100A1 Alertness bar
10/02/2003CA2479897A1 Bacteriophages useful for therapy and prophylaxis of bacterial infections
10/02/2003CA2479582A1 Muscle cells and their use in cardiac repair
10/02/2003CA2479530A1 Hiv therapeutic
10/02/2003CA2479288A1 Process for producing cytotoxic lymphocyte
10/02/2003CA2478063A1 Lymphatic and blood endothelial cell genes
10/01/2003EP1348715A2 CD19xCD3 specific polypeptides and uses thereof
10/01/2003EP1348455A1 System and Method for Processing Biological Fluids
10/01/2003EP1348343A1 Dietary supplement composition
10/01/2003EP1348019A1 System for the cell-specific and development-specific selection of differentiating embryonic stem cells, adult stem cells and embryonic germline cells
10/01/2003EP1347805A2 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body
10/01/2003EP1347776A2 Anti-inflammatory use of polycationic compounds
10/01/2003EP1347772A2 Educated nk t cells and their uses in the treatment of immune-related disorders
10/01/2003EP1347679A1 Method of inactivating viral particles in a blood product
10/01/2003EP1204655B1 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
10/01/2003EP1100830B1 Heterominibodies
10/01/2003EP1056467B1 Method for the treatment of diseases or disorders of the inner ear
10/01/2003EP0914043B1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
10/01/2003EP0783511B1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof
10/01/2003CN1446228A 校正基因 Correction gene
10/01/2003CN1446128A Compositions inchuding ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same
10/01/2003CN1446103A Treating endotoxemia and related disorders with probiotics
1 ... 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 ... 1259